Barry Gidal, professor (CHS) in the Pharmacy Practice Division, has been invited to present a pharmacology/clinical pharmacy topic at the 2013 3’s Company Pharmacy Conference in early October in Cape Town, South Africa.

Gidal’s lecture title, “Emerging Antiepileptic Drugs: New Directions, Or Same Old Path,” aligns with the 2013 conference theme “Empowering Pharmacists for the Future,” and reflects the goal of bringing pharmacists together and empowering them with business tools, clinical skills, networking opportunities, and novel ideas.

The 3’s Company Conference is a collaboration of the Academy of Pharmaceutical Sciences of South Africa (APSSA), the Independent Community Pharmacy Association (IPCA) and the South African Association of Pharmacists in Industry (SAAPI). It encompasses a cooperative spirit between the different segments of the pharmacy profession— education, research, manufacturing, development, registration, marketing, dispensing, compliance, drug-drug interactions, contraindications, adverse drug reaction reporting, and healthcare advice. The conference will be held Oct. 4-6 with an expected attendance of more than 600 delegates representing industry, academics, and healthcare.